胃癌根治术后早期复发转移的危险因素分析

曹孟轩; 胡灿; 张延强; 黄灵; 杜义安; 于鹏程; 章若岚; 徐志远; 程向东

doi:10.19401/j.cnki.1007-3639.2022.07.002

您当前的位置：

首页 >

文章列表页 >

胃癌根治术后早期复发转移的危险因素分析

专题论著 | 更新时间：2025-12-31

- 胃癌根治术后早期复发转移的危险因素分析
- Analysis of risk factors of early recurrence and metastasis after radical resection of gastric cancer
- 中国癌症杂志 2022年32卷第7期页码：588-595
- 作者机构：
  
  1. 中国科学院大学附属肿瘤医院（浙江省肿瘤医院）胃外科,中国科学院基础医学与肿瘤研究所,浙江杭州 310005
  2. 温州医科大学,浙江省肿瘤医院研究生培养基地,浙江温州 325035
  3. 浙江中医药大学第一临床医学院,浙江杭州 310053
  4. 浙江中医药大学第二临床医学院,浙江杭州 310053
- 作者简介：
  
  [ "曹孟轩（ORCID: 0000-0003-3805-324X）,硕士在读,E-mail: mengxuan00001@126.com。" ]
  徐志远（ORCID: 0000-0002-7257-6856）,博士,主任医师,中国科学院大学附属肿瘤医院（浙江省肿瘤医院）胃外科副主任,E-mail: xuzy@zjcc.org.cn;
  [ "程向东,教授,主任医师,博士研究生导师。现任中国科学院大学附属肿瘤医院（浙江省肿瘤医院）党委书记,浙江省上消化道肿瘤防控与诊治重点实验室主任,肿瘤分子诊断与智能筛查浙江省国际科技合作基地负责人,消化道肿瘤诊治创新技术浙江省工程研究中心主任,浙江省消化道肿瘤临床医学研究中心主任,浙江省上消化道肿瘤诊治技术研究中心主任。兼任中国医师协会外科医师分会肿瘤外科医师委员会副主任委员,中国抗癌协会胃癌专业委员会副主任委员,中华医学会外科学分会胃肠外科学组常务委员,浙江省抗癌协会肿瘤微创诊治专业委员会主任委员,浙江省医师协会肿瘤MDT专业委员会主任委员,浙江省中西医结合学会副会长,浙江省医学会外科学分会副主任委员,浙江肿瘤联盟胃癌专业委员会主任委员等。作为浙江省胃癌诊治领域的学科带头人,擅长开展开腹和腹腔镜微创胃癌根治术,曾连续3年获全国手术比赛第1名,多次在胃癌国际会议上进行演讲和现场手术演示;善于技术创新,自主设计新型Kissing式胰肠吻合术,使Whipple术后胰瘘和消化道出血率低于2%;创新开展累及幽门胃癌D2+淋巴结清扫术,提高根治度,降低复发风险;开创性提出经腹进胸胃食管结合部癌的手术方式及重建方式;创新性提出程氏“三步法”胃癌胃大弯区淋巴结清扫术等。国内最早开展晚期胃癌转化治疗研究,在亚洲临床肿瘤学联盟研究（CONVO-GC-1）中提供的数据居全球第3,国内第1;开展了6项相关临床研究,其中Ahead-G325研究结果入选2017年美国临床肿瘤学会胃肠肿瘤研讨会大会交流,并为2018版中国临床肿瘤学会官方指南更新贡献临床指导依据;胃癌腹膜种植转移外科治疗技术全国领先,省内最早引进术中腹腔热灌注化疗方法,率先提出腹腔化疗-手术-热疗-化疗的模式治疗腹膜转移性胃癌和卵巢切除-化疗-手术-化疗的胃癌卵巢种植治疗模式,牵头制定《胃癌卵巢转移诊断和治疗中国专家共识（2021版）》。近年来,在胃癌诊治方法、转化治疗、胃癌上皮-间充质转化发生机制、胃癌生物标志物筛选和老年胃癌患者综合治疗方面均取得了一系列重大突破和创新,作为首席科学家牵头“十四五”科技部国家重点研发计划,牵头国家“十三五”重大疑难疾病（胃癌）中西医临床协作试点项目,获得10多项国家级、省级和厅级重点项目和专项资助,累计科研经费达5 000万以上,在Molecular Cancer、Drug Resistance Updates、Cell Communication and Signaling、Journal of Natural Products等国际知名学术刊物上发表论文100多篇,其中在SCI收录期刊上发表50多篇,出版专著2部,获得国家发明专利2项、软件著作权2项,作为第一完成人获得浙江省科学技术进步三等奖1项、浙江省中医药科学技术一等奖2项和三等奖1项。" ]
- 基金信息：
  
  国家自然科学基金(82074245);国家自然科学基金(81973634)
- DOI：10.19401/j.cnki.1007-3639.2022.07.002
  中图分类号： R735.2
- 收稿：2022-06-02，
  
  纸质出版：2022-07-30
- 稿件说明：
移动端阅览
曹孟轩, 胡灿, 张延强, 等. 胃癌根治术后早期复发转移的危险因素分析[J]. 中国癌症杂志, 2022,32(7):588-595.

Mengxuan CAO, Can HU, Yanqiang ZHANG, et al. Analysis of risk factors of early recurrence and metastasis after radical resection of gastric cancer[J]. China Oncology, 2022, 32(7): 588-595.
曹孟轩, 胡灿, 张延强, 等. 胃癌根治术后早期复发转移的危险因素分析[J]. 中国癌症杂志, 2022,32(7):588-595. DOI： 10.19401/j.cnki.1007-3639.2022.07.002.

Mengxuan CAO, Can HU, Yanqiang ZHANG, et al. Analysis of risk factors of early recurrence and metastasis after radical resection of gastric cancer[J]. China Oncology, 2022, 32(7): 588-595. DOI： 10.19401/j.cnki.1007-3639.2022.07.002.

摘要

背景与目的：

目前胃癌仍是癌症死亡的重要原因

其术后复发是导致胃癌患者生存率较低的主要因素。本研究旨在探讨胃癌患者术后早期、晚期复发转移与临床病理学特征的关系

以便更好地改善胃癌预后。

方法：

回顾性分析2014年1月

#x02014;2016年1月在浙江省肿瘤医院行胃癌根治性手术后出现复发转移的188例胃癌患者的临床病理学资料

比较早期复发转移患者（

#x02264;2年）与晚期复发转移患者（

2年）的临床病理学特征的差异。

结果：

188例患者中

126例患者出现早期复发

62例患者出现晚期复发

总体中位复发时间为术后18个月。复发部位、淋巴结转移、浆膜浸润、无术前新辅助化疗、无术后辅助化疗及低分化是胃癌术后早期复发的独立危险因素。

结论：

复发部位、术前新辅助化疗、术后辅助化疗、淋巴结转移、浸润深度及组织分化程度与术后复发有关。

Abstract

Background and purpose:

At present

gastric cancer is still an important cause of cancer death

and its postoperative recurrence is the main factor leading to the low survival rate of gastric cancer. The purpose of this study was to investigate the relationship between early and late postoperative recurrence and metastasis and clinicopathological features in patients with gastric cancer in order to improve the prognosis of gastric cancer.

Methods:

The clinicopathological data of 188 patients with recurrent and metastatic gastric cancer after radical operation in Zhejiang Cancer Hospital from January 2014 to January 2016 were analyzed retrospectively. The clinicopathological characteristics of patients with early recurrence and metastasis (

#x02264;2 years) and late recurrence and metastasis (

2 years) were compared.

Results:

Among the 188 patients

126 patients had early recurrence and 62 patients had late recurrence. The overall median time of recurrence was 18 months after operation. Recurrence site

lymph nod

e metastasis

serosa infiltration

no preoperative neoadjuvant chemotherapy

no postoperative adjuvant chemotherapy and poor differentiation are independent risk factors for early postoperative recurrence of gastric cancer.

Conclusion:

The location of recurrence

preoperative neoadjuvant chemotherapy

postoperative adjuvant chemotherapy

lymph node metastasis

depth of invasion and degree of tissue differentiation are related to postoperative recurrence.

关键词

Keywords

references

BRAY F , FERLAY J , SOERJOMATARAM I , et al . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin , 2018 , 68 ( 6 ): 394 - 424 . DOI: 10.3322/caac.21492 http://doi.org/10.3322/caac.21492 http://doi.wiley.com/10.3322/caac.21492 http://doi.wiley.com/10.3322/caac.21492

JOHNSTON F M , BECKMAN M . Updates on management of gastric cancer [J ] . Curr Oncol Rep , 2019 , 21 ( 8 ): 67 . DOI: 10.1007/s11912-019-0820-4 http://doi.org/10.1007/s11912-019-0820-4 https://doi.org/10.1007/s11912-019-0820-4 https://doi.org/10.1007/s11912-019-0820-4

LIU D , LU M , LI J , et al . The patterns and timing of recurrence after curative resection for gastric cancer in China [J ] . World J Surg Oncol , 2016 , 14 ( 1 ): 305 . DOI: 10.1186/s12957-016-1042-y http://doi.org/10.1186/s12957-016-1042-y http://wjso.biomedcentral.com/articles/10.1186/s12957-016-1042-y http://wjso.biomedcentral.com/articles/10.1186/s12957-016-1042-y

GAO K , WU J . National trend of gastric cancer mortality in China (2003-2015): a population-based study [J ] . Cancer Commun , 2019 , 39 ( 1 ): 1 - 5 . DOI: 10.1186/s40880-018-0346-4 http://doi.org/10.1186/s40880-018-0346-4 http://doi.wiley.com/10.1186/s40880-018-0346-4 http://doi.wiley.com/10.1186/s40880-018-0346-4

GADDE R , TAMARIZ L , HANNA , et al . Metastatic gastric cancer (MGC) patients: can we improve survival by metastasectomy? A systematic review and meta-analysis [J ] . J Surg Oncol , 2015 , 112 ( 1 ): 38 - 45 . DOI: 10.1002/jso.23945 http://doi.org/10.1002/jso.23945 https://onlinelibrary.wiley.com/doi/10.1002/jso.23945 https://onlinelibrary.wiley.com/doi/10.1002/jso.23945

SHRIDHAR R , ALMHANNA K , HOFFE S E , et al . Increased survival associated with surgery and radiation therapy in metastatic gastric cancer: a Surveillance, Epidemiology, and End Results database analysis [J ] . Cancer , 2013 , 119 ( 9 ): 1636 - 1642 . DOI: 10.1002/cncr.27927 http://doi.org/10.1002/cncr.27927 https://onlinelibrary.wiley.com/doi/10.1002/cncr.27927 https://onlinelibrary.wiley.com/doi/10.1002/cncr.27927

CHIANG C Y , HUANG K H , FANG W L , et al . Factors associated with recurrence within 2 years after curative surgery for gastric adenocarcinoma [J ] . World J Surg , 2011 , 35 ( 11 ): 2472 - 2478 . DOI: 10.1007/s00268-011-1247-8 http://doi.org/10.1007/s00268-011-1247-8 http://link.springer.com/10.1007/s00268-011-1247-8 http://link.springer.com/10.1007/s00268-011-1247-8

SAKAR B , KARAGOL H , GUMUS M , et al . Timing of death from tumor recurrence after curative gastrectomy for gastric cancer [J ] . Am J Clin Oncol , 2004 , 27 ( 2 ): 205 - 209 . DOI: 10.1097/01.coc.0000092703.12189.a2 http://doi.org/10.1097/01.coc.0000092703.12189.a2 http://journals.lww.com/00000421-200404000-00017 http://journals.lww.com/00000421-200404000-00017

LAI J F , KIM S , KIM K , et al . Prediction of recurrence of early gastric cancer after curative resection [J ] . Ann Surg Oncol , 2009 , 16 ( 7 ): 1896 - 1902 . DOI: 10.1245/s10434-009-0473-x http://doi.org/10.1245/s10434-009-0473-x http://link.springer.com/10.1245/s10434-009-0473-x http://link.springer.com/10.1245/s10434-009-0473-x

YOO C H , NOH S H , SHIN D W , et al . Recurrence following curative resection for gastric carcinoma [J ] . Br J Surg , 2000 , 87 ( 2 ): 236 - 242 . DOI: 10.1046/j.1365-2168.2000.01360.x http://doi.org/10.1046/j.1365-2168.2000.01360.x https://academic.oup.com/bjs/article/87/2/236/6156498 https://academic.oup.com/bjs/article/87/2/236/6156498

LEE J H , KIM H I , KIM M G , et al . Recurrence of gastric cancer in patients who are disease-free for more than 5 years after primary resection [J ] . Surgery , 2016 , 159 ( 4 ): 1090 - 1098 . DOI: 10.1016/j.surg.2015.11.002 http://doi.org/10.1016/j.surg.2015.11.002 https://linkinghub.elsevier.com/retrieve/pii/S003960601500937X https://linkinghub.elsevier.com/retrieve/pii/S003960601500937X

SPOLVERATO G , EJAZ A , KIM Y , et al . Rates and patterns of recurrence after curative intent resection for gastric cancer: a United States multi-institutional analysis [J ] . J Am Coll Surg , 2014 , 219 ( 4 ): 664 - 675 . DOI: 10.1016/j.jamcollsurg.2014.03.062 http://doi.org/10.1016/j.jamcollsurg.2014.03.062 https://journals.lww.com/00019464-201410000-00008 https://journals.lww.com/00019464-201410000-00008

XU J , SHEN L , SHUI Y J , et al . Patterns of recurrence after curative D2 resection for gastric cancer: implications for postoperative radiotherapy [J ] . Cancer Med , 2020 , 9 ( 13 ): 4724 - 4735 . DOI: 10.1002/cam4.3085 http://doi.org/10.1002/cam4.3085 https://onlinelibrary.wiley.com/doi/10.1002/cam4.3085 https://onlinelibrary.wiley.com/doi/10.1002/cam4.3085

LIEBIG C , AYALA G , WILKS J A , et al . Perineural invasion in cancer: a review of the literature [J ] . Cancer , 2009 , 115 ( 15 ): 3379 - 3391 . DOI: 10.1002/cncr.24396 http://doi.org/10.1002/cncr.24396 https://onlinelibrary.wiley.com/doi/10.1002/cncr.24396 https://onlinelibrary.wiley.com/doi/10.1002/cncr.24396

CHOI J Y , HA T K , KWON S J . Clinicopathologic characteristics of gastric cancer patients according to the timing of the recurrence after curative surgery [J ] . J Gastric Cancer , 2011 , 11 ( 1 ): 46 - 54 . DOI: 10.5230/jgc.2011.11.1.46 http://doi.org/10.5230/jgc.2011.11.1.46 https://jgc-online.org/DOIx.php?id=10.5230/jgc.2011.11.1.46 https://jgc-online.org/DOIx.php?id=10.5230/jgc.2011.11.1.46

BILICI A , SEKER M , USTAALIOGLU B B O , et al . Prognostic significance of perineural invasion in patients with gastric cancer who underwent curative resection [J ] . Ann Surg Oncol , 2010 , 17 ( 8 ): 2037 - 2044 . DOI: 10.1245/s10434-010-1027-y http://doi.org/10.1245/s10434-010-1027-y http://link.springer.com/10.1245/s10434-010-1027-y http://link.springer.com/10.1245/s10434-010-1027-y

ROVIELLO F , MARRELLI D , DE MANZONI G , et al . Prospective study of peritoneal recurrence after curative surgery for gastric cancer [J ] . Br J Surg , 2003 , 90 ( 9 ): 1113 - 1119 . DOI: 10.1002/bjs.4164 http://doi.org/10.1002/bjs.4164 https://academic.oup.com/bjs/article/90/9/1113/6143338 https://academic.oup.com/bjs/article/90/9/1113/6143338

ZHU L C , XU Y S , SHAN Y Q , et al . Intraperitoneal perfusion chemotherapy and whole abdominal hyperthermia using external radiofrequency following radical D2 resection for treatment of advanced gastric cancer [J ] . Int J Hyperthermia , 2019 , 36 ( 1 ): 403 - 407 .

GLEHEN O , PASSOT G , VILLENEUVE L , et al . GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase Ⅲ study [J ] . BMC Cancer , 2014 , 14 : 183 . DOI: 10.1186/1471-2407-14-183 http://doi.org/10.1186/1471-2407-14-183 http://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-14-183 http://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-14-183

LI F X , ZHANG R P , LIANG H , et al . The pattern and risk factors of recurrence of proximal gastric cancer after curative resection [J ] . J Surg Oncol , 2013 , 107 ( 2 ): 130 - 135 . DOI: 10.1002/jso.23252 http://doi.org/10.1002/jso.23252 https://onlinelibrary.wiley.com/doi/10.1002/jso.23252 https://onlinelibrary.wiley.com/doi/10.1002/jso.23252

KANG W M , MENG Q B , YU J C , et al . Factors associated with early recurrence after curative surgery for gastric cancer [J ] . World J Gastroenterol , 2015 , 21 ( 19 ): 5934 - 5940 . DOI: 10.3748/wjg.v21.i19.5934 http://doi.org/10.3748/wjg.v21.i19.5934 http://www.wjgnet.com/1007-9327/full/v21/i19/5934.htm http://www.wjgnet.com/1007-9327/full/v21/i19/5934.htm

EOM B W , YOON H , RYU K W , et al . Predictors of timing and patterns of recurrence after curative resection for gastric cancer [J ] . Dig Surg , 2010 , 27 ( 6 ): 481 - 486 . DOI: 10.1159/000320691 http://doi.org/10.1159/000320691 https://www.karger.com/Article/FullText/320691 https://www.karger.com/Article/FullText/320691

CUNNINGHAM D , ALLUM W H , STENNING S P , et al . Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J ] . N Engl J Med , 2006 , 355 ( 1 ): 11 - 20 . DOI: 10.1056/NEJMoa055531 http://doi.org/10.1056/NEJMoa055531 http://www.nejm.org/doi/abs/10.1056/NEJMoa055531 http://www.nejm.org/doi/abs/10.1056/NEJMoa055531

YCHOU M , BOIGE V , PIGNON J P , et al . Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase Ⅲ trial [J ] . J Clin Oncol , 2011 , 29 ( 13 ): 1715 - 1721 .

LUI S A , TAN W B , TAI B C , et al . Predictors of survival outcome following radical gastrectomy for gastric cancer [J ] . ANZ J Surg , 2019 , 89 ( 1/2 ): 84 - 89 . DOI: 10.1111/ans.15011 http://doi.org/10.1111/ans.15011 https://onlinelibrary.wiley.com/doi/10.1111/ans.15011 https://onlinelibrary.wiley.com/doi/10.1111/ans.15011

HEJNA M , WÖHRER S , SCHMIDINGER M , et al . Postoperative chemotherapy for gastric cancer [J ] . Oncologist , 2006 , 11 ( 2 ): 136 - 145 . DOI: 10.1634/theoncologist.11-2-136 http://doi.org/10.1634/theoncologist.11-2-136 https://academic.oup.com/oncolo/article/11/2/136/6398170 https://academic.oup.com/oncolo/article/11/2/136/6398170

LIU T S , WANG Y , CHEN S Y , et al . An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer [J ] . Eur J Surg Oncol , 2008 , 34 ( 11 ): 1208 - 1216 . DOI: 10.1016/j.ejso.2008.02.002 http://doi.org/10.1016/j.ejso.2008.02.002 https://linkinghub.elsevier.com/retrieve/pii/S0748798308000681 https://linkinghub.elsevier.com/retrieve/pii/S0748798308000681

SAKURAMOTO S , SASAKO M , YAMAGUCHI T , et al . Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine [J ] . N Engl J Med , 2007 , 357 ( 18 ): 1810 - 1820 . DOI: 10.1056/NEJMoa072252 http://doi.org/10.1056/NEJMoa072252 http://www.nejm.org/doi/abs/10.1056/NEJMoa072252 http://www.nejm.org/doi/abs/10.1056/NEJMoa072252

WANG X , ZHAO L , LIU H F , et al . A phase Ⅱ study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer [J ] . Br J Cancer , 2016 , 114 ( 12 ): 1326 - 1333 . DOI: 10.1038/bjc.2016.126 http://doi.org/10.1038/bjc.2016.126 https://doi.org/10.1038/bjc.2016.126 https://doi.org/10.1038/bjc.2016.126

DONG S , YU J R , ZHANG Q , et al . Neoadjuvant chemotherapy in controlling lymph node metastasis for locally advanced gastric cancer in a Chinese population [J ] . J Chemother , 2016 , 28 ( 1 ): 59 - 64 . DOI: 10.1179/1973947815Y.0000000028 http://doi.org/10.1179/1973947815Y.0000000028 http://www.tandfonline.com/doi/full/10.1179/1973947815Y.0000000028 http://www.tandfonline.com/doi/full/10.1179/1973947815Y.0000000028

BECKER K , LANGER R , REIM D , et al . Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases [J ] . Ann Surg , 2011 , 253 ( 5 ): 934 - 939 . DOI: 10.1097/SLA.0b013e318216f449 http://doi.org/10.1097/SLA.0b013e318216f449 https://journals.lww.com/00000658-201105000-00014 https://journals.lww.com/00000658-201105000-00014

LEVENSON G , VORON T , PAYE F , et al . Tumor downstaging after neoadjuvant chemotherapy determines survival after surgery for gastric adenocarcinoma [J ] . Surgery , 2021 , 170 ( 6 ): 1711 - 1717 . DOI: 10.1016/j.surg.2021.08.021 http://doi.org/10.1016/j.surg.2021.08.021 https://linkinghub.elsevier.com/retrieve/pii/S0039606021007911 https://linkinghub.elsevier.com/retrieve/pii/S0039606021007911

浏览量

1965

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

人工智能在胃癌诊疗和患者预后预测中的应用现状及未来展望

胃癌中FKBP1A高表达的预后价值及其靶向PI3K/AKT对糖代谢的调控作用

胃癌脑膜转移的临床病理学特征及预后分析

胃癌组织中microRNA-210的表达与临床病理因素及预后关系的研究

胃癌组织原钙黏蛋白10 mRNA表达水平与预后的相关性